{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:57:34Z","timestamp":1771037854272,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MCT-78844"],"award-info":[{"award-number":["MCT-78844"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jclinepi.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jclinepi.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T06:47:49Z","timestamp":1518158869000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The win ratio approach did not alter study conclusions and may mitigate concerns regarding unequal composite end points in kidney transplant trials"],"prefix":"10.1016","volume":"98","author":[{"given":"Nicholas A.","family":"Fergusson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-8170","authenticated-orcid":false,"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00ebl","family":"Chass\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane W.","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg A.","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2018.02.001_bib1","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1681\/ASN.2015050524","article-title":"Relationship between eGFR decline and hard outcomes after kidney transplants","volume":"27","author":"Clayton","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib2","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/j.ajkd.2014.08.017","article-title":"GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials","volume":"64","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib4","series-title":"Evidence-based medicine and clinical trials in renal transplantation - UpToDate","author":"Alloway","year":"2015"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/ndt\/gfv269","article-title":"Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials","volume":"31","author":"Badve","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib6","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/sim.7284","article-title":"Weighted win loss approach for analyzing prioritized outcomes","volume":"36","author":"Luo","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2106\/JBJS.K.01287","article-title":"Use and interpretation of composite end points in orthopaedic trials","volume":"94","author":"Busse","year":"2012","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1157\/13116656","volume":"61","author":"Ferreira-Gonz\u00e1lez","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cct.2016.04.001","article-title":"The win ratio approach to analyzing composite outcomes: an application to the EVOLVE trial","volume":"48","author":"Abdalla","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib11","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/sim.3923","article-title":"Generalized pairwise comparisons of prioritized outcomes in the two-sample problem","volume":"29","author":"Buyse","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib12","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcin.2016.08.025","article-title":"Computing methods for composite clinical endpoints in unprotected left main coronary artery revascularization: a post hoc analysis of the DELTA registry","volume":"9","author":"Capodanno","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehu262","article-title":"Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial","volume":"36","author":"Bakal","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4244\/EIJ-D-16-00745","article-title":"Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial","volume":"13","author":"Milojevic","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","article-title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","volume":"4","author":"Knoll","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2213-8587(15)00415-5","article-title":"When evidence doesn\u2019t generalise: the case of ACE inhibition","volume":"4","author":"Webster","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ndt\/gfm574","article-title":"The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation - study design","volume":"23","author":"Knoll","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","article-title":"Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians","volume":"19","author":"Carpenter","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib19","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/(SICI)1097-0258(19961230)15:24<2763::AID-SIM319>3.0.CO;2-O","article-title":"Evaluation of long-term survival: use of diagnostic and robust estimators with Cox\u2019s proportional hazards model","volume":"15","author":"Valsecchi","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2018.02.001_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/pst.1763","article-title":"A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components","volume":"15","author":"Dong","year":"2016","journal-title":"Pharm Stat"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617305991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617305991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T01:37:10Z","timestamp":1535074630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435617305991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":21,"alternative-id":["S0895435617305991"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2018.02.001","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The win ratio approach did not alter study conclusions and may mitigate concerns regarding unequal composite end points in kidney transplant trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}